Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Urovant Sciences Ltd.Listing unverified | Buy | $56.5K | conv 23Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $62.3K | conv 23Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $58.6K | conv 23Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $62.6K | conv 30Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $61.7K | conv 23Cluster | SEC | |
Urovant Sciences Ltd.Listing unverified | Buy | $53K | conv 47ClusterFirst in 12mo | SEC | |
Arbutus Biopharma CorpListing on record | BuyD (derivative) | $66.4M | ClusterFirst in 12mo | SEC |